Summary OTC Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Findings Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in the United Kingdom
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in the United Kingdom
Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom otc pharmaceuticals market with five year forecasts
Synopsis Essential resource for top-line data and analysis covering the United Kingdom otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Reasons To Buy What was the size of the United Kingdom otc pharmaceuticals market by value in 2015?
What will be the size of the United Kingdom otc pharmaceuticals market in 2020?
What factors are affecting the strength of competition in the United Kingdom otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the United Kingdom's otc pharmaceuticals market?
Key Highlights The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.
The UK OTC pharmaceuticals market generated total revenues of $4,680.9m in 2015, representing a CAGR of 2.0% between 2011 and 2015.
Analgesics registered the highest sales value in the UK OTC Pharmaceuticals market in 2015, with total sales of $840.7m, equivalent to 18.0% of the market's overall value.
The delisting of medicines aimed at encouraging self-medication has improved availability to consumers. As the UK government embarks on further austerity, self-medication constitutes an easy method of reducing spending on healthcare.
Our reports have been used by over 10K customers, including:
Animal Antibiotics & Antimicrobials Market Research Report by Product (Aminoglycosides, Cephalosporins, Fluoroquinolones, Lincosamides, and Macrolides), by Mode of Delivery (Injections, Oral Powders, Oral Solutions, and Premixes), by Type of Animal - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global...
Women’s Health - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Women’s Health - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Women’s Health pipeline products with comparative analysis of the products at various stages...
Migraine - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H1 2020, provides an overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated attacks of severe...
Insomnia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Insomnia – Pipeline Review, H1 2020, provides an overview of the Insomnia (Central Nervous System) pipeline landscape. Insomnia is a sleep disorder that is characterized by difficulty...
Aspergillosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis – Pipeline Review, H1 2020, provides an overview of the Aspergillosis (Infectious Disease) pipeline landscape. Aspergillosis is an infection or allergic response...
Premenstrual Syndrome Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Premenstrual Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Premenstrual Syndrome Clinical trials scenario.This report provides top line data relating to the clinical trials...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.